Track the 엔솔바이오사이언스 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 엔솔바이오사이언스 has published 21 reports. The latest transaction was reported on 27 May 2026 (Purchase). Among the most active insiders: 형인우. The full history is accessible without an account.
21
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Ensol Bioscience is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.